AbCellera Overview
- Founded
-
2012

- Status
-
Public
- Employees
-
386

- Stock Symbol
-
ABCL

- Investments
-
6
- Share Price
-
$10.27
- (As of Monday Closing)
AbCellera General Information
Description
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
- 2215 Yukon Street
- Vancouver, British Columbia V5Y 0A1
- Canada
+1 (604) 000-0000
AbCellera Timeline
AbCellera Stock Performance
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$10.27 | $10.65 | $5.42 - $22.63 | $3.03B | 285M | 2.51M | $0.72 |
AbCellera Financials Summary
In Thousands, USD |
TTM 31-Mar-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
---|---|---|---|---|
EV | 2,078,845 | 3,303,197 | 10,746,359 | |
Revenue | 489,063 | 375,203 | 233,155 | 11,612 |
EBITDA | 306,731 | 238,294 | 169,322 | (310) |
Net Income | 204,818 | 153,464 | 118,918 | (2,211) |
Total Assets | 1,592,289 | 1,318,569 | 1,005,536 | 23,488 |
Total Debt | 40,276 | 40,065 | 4,390 | 6,891 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
AbCellera Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
AbCellera Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various othe
Biotechnology
Vancouver, Canada
386
As of 2021
00000
0.000
0000-00-00
00000000
00000
AbCellera Competitors (55)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Vir | Formerly VC-backed | San Francisco, CA | 000 | 00000 | 000000 - 000 | 00000 |
00000000000 000 | Formerly VC-backed | South San Francisco, CA | 00 | 000000&0 | ||
00000000 000000 | Formerly VC-backed | Emeryville, CA | 000 | 00000 | 00000000000 | 00000 |
000000 00000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
00000000 000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000 - | 00000 |
AbCellera Executive Team (15)
AbCellera Board Members (8)
Name | Representing | Role | Since |
---|---|---|---|
Andrew Lo | AbCellera | Board Member | 000 0000 |
John Hamer Ph.D | Self | Board Member | 000 0000 |
John Montalbano | Self | Board Member | 000 0000 |
Michael Hayden Ph.D | Self | Board Member | 000 0000 |
Michael Hayden Ph.D | Self | Board Member | 000 0000 |
AbCellera Signals
AbCellera Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
AbCellera Investments & Acquisitions (6)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000000000 | 10-Sep-2021 | 0000000000 | 0000 | Drug Discovery | 000000 00 |
000000 000000 | 25-Jan-2021 | 0000 00000 | 000 | Drug Discovery | |
0000000 | 18-Nov-2020 | 0000000000 | 0000 | Drug Delivery | 0000 0000 |
000000 | 30-Sep-2020 | 00000 0000 | 000.00 | Drug Discovery | 0000 0000 |
Dualogics (OrthoMab) | 20-Aug-2020 | Merger/Acquisition | Biotechnology | 0000 0000 |
AbCellera Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
Trianni | Drug Delivery | San Francisco, CA | 2008 |
0000000000000 | Drug Discovery | Arlington, MA | 0000 |